Thomas Möller is the Vice-Chairman of the Board of Directors. Mr. Möller is a General Partner at BioMedPartners founded in 2003, one of the leading venture capital firms in the early- and mid-stage healthcare sectors in Europe. He is responsible for a series of venture investments of the BioMed Group, with Degradable Solutions AG, idiag AG, Spinelab AG, Symetis SA and Xiril AG, still active. Previously he was representing BioMedPartners in Arpida AG, Thommen Medical AG, Santhera Pharmaceuticals AG and MediService AG. Mr. Möller has a degree as Swiss certified public accountant as well as a master degree in economics and business administration from the University of Basel. He is currently Board member of Spinelab AG, Idiag AG, Xiril AG, Sequana Medical AG and the management companies of the BioMed Group.